Cargando…

Corrigendum: Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State

Detalles Bibliográficos
Autores principales:	Louloudis, Georgios, Ambrosini, Samuele, Paneni, Francesco, Camici, Giovanni G., Benke, Dietmar, Klohs, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790749/ https://www.ncbi.nlm.nih.gov/pubmed/35097032 http://dx.doi.org/10.3389/fcvm.2021.820282

Ejemplares similares

Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State
por: Louloudis, Georgios, et al.
Publicado: (2021)

The role of monocytosis and neutrophilia in atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2018)

The Diagnostic Value of a Monocytosis
por: Dutton, H. R.
Publicado: (1928)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody
por: Hopkins, Paul N., et al.
Publicado: (2015)

THE CYTOKINETICS OF MONOCYTOSIS IN ACUTE SALMONELLA INFECTION IN THE RAT
por: Volkman, Alvin, et al.
Publicado: (1974)

Monocytosis in the BXSB model for systemic lupus erythematosus
Publicado: (1984)

Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
por: Di Taranto, Maria Donata, et al.
Publicado: (2017)

Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia
por: Pęczek, Piotr, et al.
Publicado: (2021)

Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
por: Tomlinson, Brian, et al.
Publicado: (2021)

PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2016)

PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
por: Guo, Qianyun, et al.
Publicado: (2020)

Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia
por: Basiak, Marcin, et al.
Publicado: (2022)

Age‐associated vascular inflammation promotes monocytosis during atherogenesis
por: Du, Wei, et al.
Publicado: (2016)

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals
por: van Zeventer, Isabelle A., et al.
Publicado: (2022)

The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapies
por: Costantino, Sarah, et al.
Publicado: (2020)

microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production
por: Dong, Jianjie, et al.
Publicado: (2020)

PCSK9 Inhibitors for the Management of Mitotane-Induced Hypercholesterolemia in Adrenocortical Carcinoma
por: Aurora, John A, et al.
Publicado: (2021)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity.
por: Eccles, S. A., et al.
Publicado: (1976)

Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients
por: Tsai, Jih-Jin, et al.
Publicado: (2017)

Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis
por: Hwang, Sang Mee, et al.
Publicado: (2020)

ZNFX1 Deficiency in a Child with Interstitial Pneumonitis and Peripheral Monocytosis
por: Al-Saud, Bandar, et al.
Publicado: (2023)

Chronic Idiopathic Neutrophilia in Two Twins
por: Miniero, Roberto, et al.
Publicado: (2014)

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
por: Jatem, Elias, et al.
Publicado: (2020)

The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
por: Meshkov, Alexey, et al.
Publicado: (2021)

PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Epigenetic Control of Mitochondrial Function in the Vasculature
por: Mohammed, Shafeeq A., et al.
Publicado: (2020)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

p210(BCR‐ABL1)‐ Chronic myeloid leukemia presents with monocytosis
por: Wang, Xiaofei, et al.
Publicado: (2020)

Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia
por: Sokolov, Victor, et al.
Publicado: (2019)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
por: Seidah, Nabil G.
Publicado: (2021)

PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia
por: Kaya, Esra, et al.
Publicado: (2017)

Neutrophilia and hyperamylasemia in patients with immediate food allergy
por: Kimura, Mitsuaki, et al.
Publicado: (2019)

Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding
por: Mangaonkar, Abhishek A., et al.
Publicado: (2021)

A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation
por: Law, Sze-Ming, et al.
Publicado: (2022)

Epigenetic remodeling in heart failure with preserved ejection fraction
por: Ambrosini, Samuele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7b05rvl9s0hr98e60l5onepid